Hypoadiponectinemia is speculated to play a key role in the relationship between obesity
and COVID‐19 respiratory failure. However, only one study has examined adiponectin …

Purpose The beneficial effect of glucocorticoids in coronavirus disease (COVID-19) is
established, but whether adrenal cortisol secretion is impaired in COVID-19 is not fully …

Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19:
systematic review and network meta-analysis - PMC Back to Top Skip to main content NIH …

Importance A World Health Organization (WHO) meta-analysis found that tocilizumab was
associated with reduced mortality in hospitalized patients with COVID-19. However …

SARS-CoV-2 virus may cause COVID-19 disease, which causes mild-to-moderate disease
in 80% of laboratory-confirmed cases which may be community-managed. A considerable …

Background Zinc is a trace element that plays a role in stimulating innate and acquired
immunity. The role of zinc in critically ill patients with COVID-19 remains unclear. This study …

There are many pharmacologic therapies that are being used or considered for treatment of
coronavirus disease 2019 (COVID-19), with rapidly changing efficacy and safety evidence …

Objective To summarise the available information on efficacy and safety of
immunomodulatory agents in SARS-CoV-2 infection. Methods As part of a European …

Vascular endothelial cells are major participants in and regulators of immune responses and
inflammation. Vascular endotheliitis is regarded as a host immune-inflammatory response of …

Introduction The results of studies of tocilizumab (TCZ) in COVID‐19 are contradictory. Our
study aims to update medical evidence from controlled observational studies and …